Pricing Log in Create free account

Aditxt, Inc. (ADTX) vs Longeveron Inc. (LGVN)

Aditxt, Inc. and Longeveron Inc. are both Biotechnology companies. Longeveron Inc. is the larger, with a market value of $5.1M against $4.4M — 1.2× the size. Longeveron Inc. grew revenue faster over the last twelve months: −42.7% against −74.2%. Longeveron Inc. has the higher net margin (−1,977.6% vs −372,998.6%) and the lower return on invested capital (−4,549.0% vs 0.00%). Across the 14 metrics below, Longeveron Inc. leads on 9 and Aditxt, Inc. on 5.

Valuation

Metric ADTX LGVN Biotechnology median
P/E n/m n/m 8.58
P/S n/m 4.20 10.29
P/B n/m 0.48 2.29
Price to free cash flow n/m n/m 21.93
EV/EBITDA n/m 0.19 0.67
EV/Sales 73.26 (3.63) 9.89
Earnings yield 0.00% (622.64%) (31.56%)
Free cash flow yield 0.00% (417.71%) (23.42%)

Profitability

Metric ADTX LGVN Biotechnology median
Gross margin 20.28% 69.76% 65.77%
Operating margin (128,143.36%) (1,992.84%) 0.00%
Net margin (372,998.60%) (1,977.59%) 0.00%
Free cash flow margin (129,979.72%) (1,755.69%) 0.00%
Return on equity 549.59% (203.61%) (54.09%)
Return on assets (236.38%) (145.64%) (47.78%)
Return on invested capital 0.00% (4,549.04%) 0.00%

Growth

Metric ADTX LGVN Biotechnology median
Revenue growth (TTM) (74.19%) (42.74%) 5.83%
EPS growth (last fiscal year) (918.27%) 50.76% 29.36%
Revenue growth, 5-year CAGR — (26.60%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADTX LGVN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.06 2.63 4.80
Net debt to EBITDA 0.18 0.20 0.97

Dividend

Metric ADTX LGVN Biotechnology median
Dividend yield — — 0.44%
Payout ratio — — —

Size

Metric ADTX LGVN Biotechnology median
Market cap 4.39m 5.07m 153.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack